On Monday shares of Energous Corporation (NASDAQ:WATT) closed at $8.14. Ascendiant Capital Markets initiated coverage on shares of Energous Corp (NASDAQ:WATT) in a research report released on 4 May. The firm issued a buy rating and a $13.00 price objective on the stock.
Ceres, Inc. (NASDAQ:CERE) in last trading activity fell -2.36% to close at $2.48. Company weekly performance is 30.53% while its quarterly performance stands at 55.00%. Ceres, Inc. (NASDAQ:CERE) is -7.08% away from its 52 week high. Ceres, Inc. (NASDAQ: CERE) announced that the company has licensed its Persephonebioinformatics software to global seed potato developer, HZPC Holland BV. The software license agreement provides a non-exclusive license to HZPC as well as professional support services.
On last trading day IGI, Laboratories, Inc. (NYSEMKT:IG) increased 4.77% to close at $5.27. Its volatility for the week is 5.41% while volatility for the month is 5.84%. IG’s sales growth for past 5 years was 54.70% and its EPS growth for past 5 years was 16.80%. IGI, Laboratories, Inc. (NYSEMKT:IG) monthly performance is -35.97%. An investigation on behalf of investors of IGI Laboratories, Inc. (NYSEMKT:IG) shares over potential securities laws violations by IGI Laboratories and certain of its directors and officers in connection certain financial statements was announced.
On last trading day Pfizer Inc. (NYSE:PFE) moved down -0.18% to close at $33.96. Its volatility for the week is 1.31% while volatility for the month is 1.35%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is -3.38%. Pfizer Inc. (NYSE:PFE) has purchased a minority stake in Dutch biopharmaceutical company AM-Pharma, which is working on treatments for conditions including acute kidney injury, and has an exclusive option to buy the whole company.
On last trading day General Moly, Inc. (NYSEMKT:GMO) increased 4.88% to close at $0.75. Its volatility for the week is 4.40% while volatility for the month is 8.98%. GMO’s EPS growth for past 5 years was 3.00%. General Moly, Inc. (NYSEMKT:GMO) monthly performance is 47.04%. On 4 May, General Moly, Inc. (NYSEMKT:GMO) said its first-quarter net loss widened to $3.8 million or $0.04 per share from $2.4 million or $0.03 per share for the year ago period. There were no revenues in either period. Total expenses climbed to $3.1 million from $2.4 million, amid higher general and administrative expense.